The researchers found that one metabolite, butyrate, was the driver of this effect. Butyrate, a short-chain fatty acid (SCFA) produced by certain gut bacteria in the fiber fermentation process, stimulates the release of GLP-1, which we've come to understand plays such an important role in communicating to the brain that feeling of 'fullness' when we eat. Semaglutide drugs like Ozempic synthetically create this gut-brain scenario, though in a more potent way that doesn't face the same kind of rapid deterioration as when it occurs naturally.
36
254 reads
CURATED FROM
IDEAS CURATED BY
If the title made you think “Well, science has spoken, the case is closed, let’s all jump on the Oatzempic train already!”, please do not read this.
“
Read & Learn
20x Faster
without
deepstash
with
deepstash
with
deepstash
Personalized microlearning
—
100+ Learning Journeys
—
Access to 200,000+ ideas
—
Access to the mobile app
—
Unlimited idea saving
—
—
Unlimited history
—
—
Unlimited listening to ideas
—
—
Downloading & offline access
—
—
Supercharge your mind with one idea per day
Enter your email and spend 1 minute every day to learn something new.
I agree to receive email updates